Cipla is involved in the pharmaceutical industry. Pharmaceutical products are produced, developed, sold, and distributed by Cipla Limited and its affiliates in South Africa, India, the US, and other countries. Cipla supplies pharmaceutical and personal care products, such as the antidepressant escitalopram oxalate, lamivudine, and fluticasone propionate, as well as active pharmaceutical ingredients to other producers. The biggest producer of antiretroviral medications worldwide is Cipla.
Cipla – Quick Overview
| Particular | Details |
| Company Name | Cipla Limited |
| Former Name | Chemical, Industrial & Pharmaceutical Laboratories Ltd. (1935–1984) |
| Type | Public Listed Pharmaceutical Company |
| Industry | Pharmaceuticals & Healthcare |
| Founded / Incorporated | 17 August 1935 |
| Founder | Dr. Khwaja Abdul Hamied |
| Headquarters | Mumbai, Maharashtra, India |
| Chairman | Yusuf K. Hamied (Non-Executive Chairman) |
| MD & Global CEO | Umang Vohra (leadership changes announced for 2026) |
| Core Business | Development, manufacture & marketing of generic & branded medicines, APIs, biosimilars & healthcare products |
| Product Focus | Respiratory, cardiovascular, anti-infectives, oncology, diabetes, paediatrics & more |
| Global Presence | Operations in ~86+ countries |
| Manufacturing Footprint | 47+ manufacturing locations worldwide |
| Stock Exchange Listing | BSE & NSE (Ticker: CIPLA) |
| Employees | ~27,764+ (Mar 2024) |
| Market Position | One of India’s largest pharmaceutical companies; major global generic player |
| Notable Recognition | Known for affordable drug access, including past pioneering HIV-therapy pricing |
| Official Website | cipla.com |
Net Worth and Market Cap
Cipla’s net worth, or market capitalization, is INR 1.06 trillion. 961.93 billion is the enterprise value.
Corporate leadership
Khwaja Abdul Hamied chose to pursue a doctorate in chemistry in order to support the Swadeshi movement after meeting Mahatma Gandhi in the early 1920s. Hamied established Cipla as the Chemical, Industrial & Pharmaceutical Laboratories in Mumbai in 1935. With its headquarters located in Mumbai, Cipla Limited is a multinational pharmaceutical corporation based in India. The MD, Global Chief Executive Officer, and Executive Director is Umang Vohra B.E., M.B.A., while the President and Global Chief Scientific Officer is Pradeep Bhadauria.
Overview of Services
The business is divided into two segments: New Ventures and Pharmaceuticals. For a variety of therapeutic areas, including MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, obesity, arrhythmia, lipid abnormalities and diabetes, central nervous system, HIV/AIDS, respiratory, etc.
The company also operates in the biosimilars, specialty, and consumer healthcare industries. Founded in 1935, Cipla Limited is headquartered in Mumbai, India.
Scale of Operations
Complex generic medications for important medical conditions like respiratory, urology, anti-retroviral, and cardiology is part of its wide range of products. Along with other important emerging regions, the corporation is well-established in its home markets of North America, South Africa, and India. With pride, Cipla is the second-largest pharmaceutical firm in South Africa and the third-largest in India. Cipla offers its goods in 86 countries and has 47 manufacturing facilities worldwide. It is India’s third-biggest pharmaceutical manufacturer.
